СУСТАМАР: противодействие воспалению, аналгезия, хондропротекция и высокая безопасность в лечении остеоартроза

Ключевые слова: Сустамар, остеоартроз, хондропротекторный эффект, мартиния душистая, артроз, артрит, остеохондроз, остеохондропатия.

Подготовила Лариса Стрильчук

Опубликовано в газете "Medical Nature" №1(21)'2017

Список литературы 

1. Rogoveanu OC, Streba CT, Vere CC et al. Superior digestive tract side effects after prolonged treatment with NSAIDs in patients with osteoarthritis. J Med Life. 2015 Oct-Dec; 8(4): 458–461.
2. Mallen SR, Essex MN, Zhang R. Gastrointestinal tolerability of NSAIDs in elderly patients: a pooled analysis of 21 randomized clinical trials with celecoxib and nonselective NSAIDs. Curr Med Res Opin. 2011 Jul; 27(7):1359-66.
3. Nissen SE, Yeomans ND, Solomon DH et al. Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis. N Engl J Med 2016:2519-2529.
4. Bhala N, Emberson J, Merhi A et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013 Aug 31;382(9894):769-79.
5. Bresalier RS, Sandler RS, Quan H, et al. for the adenomatous polyp prevention on vioxx (APPROVe) Trial Investigators. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Eng J Med. 2005;352:1092–1102. 
6. Solomon SD, McMurray JJ, Pfeffer MA, et al. Adenoma Prevention with Celecoxib (APC) Study Investigators. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Eng J Med. 2005;352:1071–80.
7. King C, Yung A. Outcome of Treatment of Osteoarthritis with Arthroscopic Debridement and Autologous Conditioned Plasma. Malays Orthop J. 2017 Mar;11(1):23-27.
8. Suntiparpluacha M, Tammachote N, Tammachote R. Triamcinolone acetonide alters expressions of matrix metalloproteinase-3 gene in primary human chondrocytes. Genomics and Genetics. Vol 9, No 2&3 (2016): 66-71
9. Riis RG, Henriksen M, Klokker L et al. The effects of intra-articular glucocorticoids and exercise on pain and synovitis assessed on static and dynamic magnetic resonance imaging in knee osteoarthritis: exploratory outcomes from a randomized controlled trial.Osteoarthritis Cartilage. 2017 Apr;25(4):481-491.
10. Haseeb A, Ansari MY, Haqqi TM. Harpagoside suppresses IL-6 expression in primary human osteoarthritis chondrocytes. J Orthop Res. 2017 Feb;35(2):311-320.
11. Chrubasik S, Künzel O, Thanner J et al. A 1-year follow-up after a pilot study with Doloteffin for low back pain. Phytomedicine. 2005 Jan;12(1-2):1-9.
12. Andersen ML, Santos EH, Seabra Mde L et al. Evaluation of acute and chronic treatments with Harpagophytum procumbens on Freund's adjuvant-induced arthritis in rats. J Ethnopharmacol. 2004 Apr;91(2-3):325-30.
13. Mncwangi N, Chen W, Vermaak I et al. Devil's Claw-a review of the ethnobotany, phytochemistry and biological activity of Harpagophytum procumbens. J Ethnopharmacol. 2012 Oct 11;143(3):755-71.
14. Stewart KM, Cole D.The commercial harvest of devil's claw (Harpagophytum spp.) in southern Africa: the devil's in the details. J Ethnopharmacol. 2005 Sep 14;100(3):225-36.
15. Abdelouahab N, Heard CM. Dermal and transcutaneous delivery of the major glycoside constituents of Harpagophytum procumbens (Devil's Claw) in vitro. Planta Med. 2008 Apr; 74(5):527-31.
16. Spelman K, Burns J, Nichols D et al. Modulation of cytokine expression by traditional medicines: a review of herbal immunomodulators. Altern Med Rev. 2006 Jun;11(2):128-50.
17. Georgiev M.I., Ivanovska N, Alipieva K. et al. Harpagoside: from Kalahari desert to pharmacy shelf. Phytochemistry 92(2013); 8-15.